PUBLISHED ON: August 6, 2015 | Duration: 5 min, 35 sec
R V Bubna, MD of Sharda Cropchem, tells NDTV that the adverse euro/dollar movement hit the company's bottom line and margin in the first quarter. The company expects to increase registrations by 150-200 in FY16, he adds.
